C4 Therapeutics Files $400M Shelf Offering for Mixed Securities
ByAinvest
Friday, Nov 21, 2025 5:17 pm ET1min read
CCCC--
C4 Therapeutics has filed a shelf registration to offer up to $400M in securities, which may include common stock, preferred stock, debt securities, warrants, or units in one or more combinations and tranches. This offering will enable the company to raise capital for various purposes, including general corporate purposes, research and development, and strategic transactions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet